Study to Evaluate CCS1477 in Advanced Tumours
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Metastatic Castration-Resistant Prostate Cancer|Metastatic Breast Cancer|Non-small Cell Lung Cancer|Advanced Solid Tumors
Interventions: DRUG: CCS1477|DRUG: Abiraterone acetate|DRUG: Enzalutamide|DRUG: Darolutamide|DRUG: Olaparib|DRUG: Atezolizumab
Sponsor: CellCentric Ltd.